AGAMREE 40 mg/ml oral suspension
SNT-IV-VAM-011
Approved small_molecule active
Quick answer
AGAMREE 40 mg/ml oral suspension for Duchenne Muscular Dystrophy is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Approved
- Modality
- small_molecule
- Status
- active